Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Salma Parvin, Ph.D.

Concepts (81)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Salma Parvin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Salma Parvin has written about over time.
Proto-Oncogene Proteins c-myc, 2 publications between 2015 and 2021, average publication date September 2018. Adaptor Proteins, Signal Transducing, 2 publications between 2018 and 2019, average publication date January 2019. Palatine Tonsil, 1 publications between 2019 and 2019, average publication date August 2019. Poly(ADP-ribose) Polymerases, 1 publications between 2019 and 2019, average publication date August 2019. Proto-Oncogene Proteins, 1 publications between 2019 and 2019, average publication date August 2019. Lymphoma, Large B-Cell, Diffuse, 2 publications between 2019 and 2020, average publication date March 2020. Histone Demethylases, 1 publications between 2020 and 2020, average publication date June 2020. Receptors, Notch, 1 publications between 2021 and 2021, average publication date October 2021. Leukemia, Lymphocytic, Chronic, B-Cell, 3 publications between 2021 and 2023, average publication date May 2022. Culture Media, Conditioned, 1 publications between 2023 and 2023, average publication date October 2023. fms-Like Tyrosine Kinase 3, 1 publications between 2023 and 2023, average publication date October 2023. Immunoglobulin Variable Region, 1 publications between 2023 and 2023, average publication date October 2023.

To see the data from this visualization as text, click here.
Parvin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (81)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.